Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue 3, 2006, Pages 324-326

  Barreiro, Pablo ^a   Del Romero, Jorge ^b   Leal, Manuel ^c   Hernando, Victoria ^b   Asencio, Román ^c   De Mendoza, Carmen ^a   Labarga, Pablo ^a   Núñez, Marina ^a   Ramos, José Tomás ^d   González Lahoz, Juan ^a   Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b CENTRO SANITARIO SANDOVAL   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Antiretroviral therapy; HIV; Sexual transmission; Vertical transmission; Viral load

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ANTIRETROVIRUS AGENT; LAMIVUDINE; NEVIRAPINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; ZIDOVUDINE;

ADULT; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; FETUS DEATH; FOLLOW UP; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; SEROCONVERSION; SEXUAL TRANSMISSION; TREATMENT OUTCOME; TWIN PREGNANCY; VERTICAL TRANSMISSION; VIREMIA; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES;

EID: 33750303528     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000243091.40490.fd     Document Type: Review

References (13)

1. Chen J, Phillips K, Kanouse D, et al. Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspect. 2001;33:144-152.
2. Castilla J, del Romero J, Hernando V, et al. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr. 2005;40:96-101.
3. European Collaborative Study. Mother-to-child transmission of HIV-infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458-465.
4. Englert Y, van Vooren J, Place I, et al. Assisted reproduction technology in HIV-infected couples. Hum Reprod. 2001;16:1309-1315.
5. Semprini A, Vucetich A, Hollander L. Sperm washing, use of HAART and role of elective caesarean section. Curr Opin Obstet Gynecol. 2004;16:465-470.
6. Coll O, Suy A, Figueras F, et al. Decreased pregnancy rate after in-vitro fertilization in HIV-infected women receiving HAART. AIDS. 2006;20:121-123.
7. Vernazza P, Hollander L, Semprini A, et al. HIV-discordant couples and parenthood: how are we dealing with the risk of transmission? AIDS. 2006;20:365-366.
8. Mandelbrot L, Heard I, Henrion-Geant E, et al. Natural conception in HIV-negative women with HIV-infected partners. Lancet. 1997;349:850-851.
9. Thorne C, Newell M. The safety of antiretroviral drugs in pregnancy. Expert Opinion on Drug Safety. 2005;4:323-335.
10. Burns D, Landesman S, Wright D, et al. Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of HIV type 1. J Infect Dis. 1997;175:1206-1210.
11. Magder L, Mofenson L, Paul M, et al. Risk factors for in utero and intrapartum transmission of HIV. J Acquir Immune Defic Syndr. 2005;38:87-95.
12. Massad L, Springer G, Jacobson L, et al. Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV. AIDS. 2004;18:281-286.
13. Suy A, Martinez E, Coll O, et al. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS. 2006;20:59-66.